LATE-BREAKING ABSTRACT: TRILOGY: a phase III study to evaluate the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) in COPD patients

Mapping Intimacies ◽

10.1183/13993003.congress-2016.pa995 ◽

2016 ◽

Author(s):

Dave Singh ◽

Alberto Papi ◽

Massimo Corradi ◽

Isabella Montagna ◽

Catherine Francisco ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Glycopyrronium Bromide ◽

Copd Patients ◽

Phase Iii Study ◽

Formoterol Fumarate

Download Full-text

LATE-BREAKING ABSTRACT: TRINITY: A phase III study to compare the efficacy and safety of an extrafine triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide (GB) pMDI (CHF5993) with tiotropium (Tio) and a free triple combination of BDP/FF (Foster®) + Tio in COPD patients

10.1183/13993003.congress-2016.oa1972 ◽

2016 ◽

Author(s):

Jorgen Vestbo ◽

Massimo Corradi ◽

Isabella Montagna ◽

Géraldine Cohuet ◽

Catherine Francisco ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Glycopyrronium Bromide ◽

Copd Patients ◽

Phase Iii Study ◽

Formoterol Fumarate

Download Full-text

Efficacy and Safety of the Novel, Long-Acting Antimuscarinic, Aclidinium Bromide, in COPD Patients in a Phase III Study: ACCLAIM/COPD II.

10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a6178 ◽

2009 ◽

Cited By ~ 2

Author(s):

S Rennard ◽

J Donohue ◽

E Bateman ◽

N Gross ◽

E Garcia Gil ◽

...

Keyword(s):

Phase Iii ◽

The Novel ◽

Efficacy And Safety ◽

Copd Patients ◽

Phase Iii Study ◽

Aclidinium Bromide ◽

Long Acting

Download Full-text

Phase III Study on Efficacy and Safety of Triple Combination (Exenatide/Metformin/Biphasic Insulin Aspart) Therapy for Type 2 Diabetes Mellitus

American Journal of Therapeutics ◽

10.1097/mjt.0000000000000431 ◽

2018 ◽

Vol 25 (6) ◽

pp. e609-e616 ◽

Cited By ~ 1

Author(s):

Ke Su ◽

Chunmei Lv ◽

Zongwen Ji ◽

Yishu Wang ◽

Haifeng Wang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Biphasic Insulin ◽

Phase Iii Study

Download Full-text

[PP.12.23] A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION

Journal of Hypertension ◽

10.1097/01.hjh.0000523533.01598.7c ◽

2017 ◽

Vol 35 ◽

pp. e193

Author(s):

H. Lee ◽

S. Park

Keyword(s):

Essential Hypertension ◽

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results

BMC Pulmonary Medicine ◽

10.1186/1471-2466-11-51 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 11

Author(s):

Miron A Bogdan ◽

Hisamichi Aizawa ◽

Yoshinosuke Fukuchi ◽

Michiaki Mishima ◽

Masaharu Nishimura ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Copd Patients ◽

Study Results ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Phase III Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH

Case Medical Research ◽

10.31525/ct1-nct04085601 ◽

2019 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718874797.793499746 ◽

2014 ◽

Author(s):

Mark Levis

Keyword(s):

At Risk ◽

Uric Acid ◽

Tumor Lysis Syndrome ◽

Phase Iii ◽

Efficacy And Safety ◽

Tumor Lysis ◽

Plasma Uric Acid ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text